ArticleEnvironmental and occupational health practice2025
Impact of the COVID-19 pandemic on international business travel and associated health issues: a survey of Japanese public companies.
Article in Environmental and occupational health practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Methods: A cross-sectional questionnaire survey was conducted among listed companies in Japan between September and December 2021. The survey targeted general affairs and human resources departments of 3,845 companies, yielding 251 valid responses (6.5% response rate). The questionnaire covered the necessity of business travel, health concerns before and after COVID-19, and expectations for occupational health support. Statistical analyses, including Pearson's chi-square test and text mining, were performed to evaluate trends. Results: Before COVID-19, key health concerns included medical issues during travel (82.2%), infectious disease prevention (69%), and general health management (19.7%). Post-pandemic, priorities shifted to COVID-19 prevention, infectious disease control, and mental health support. Large companies emphasized psychological care, while smaller firms focused on infectious disease management. Business travel remained crucial for 85% of respondents, particularly for on-site guidance and sales. Conclusions: The pandemic underscored the need for comprehensive health management for IBTs, incorporating infection control, psychological support, and preventive care. As global travel resumes, companies must reassess health strategies to mitigate risks and ensure traveler well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.